Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …

The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

The ultimate goal of glaucoma management is the preservation of patients' visual function
and quality of life (QoL). The disease itself as well as the medical or surgical treatment can …

Purpose To evaluate the prevalence of Demodex blepharitis by its pathognomonic sign,
collarettes, in patients presenting for any reason to eye care clinics in the United States …

Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to
reduce intraocular pressure remains the mainstay treatment. These eye drops frequently …

Introduction: This review discusses the evidence concerning the effect of topical medications
and their preservatives on the ocular surface in glaucoma patients. The role of topical anti …

Glaucoma is a common disease with an increasing prevalence [1]. Ocular surface disease
(OSD) is also common, and its prevalence is increasing [2, 3], due in part to the adverse …

Introduction: Several large, randomized, prospective clinical trials have demonstrated that
medical therapy to reduce intraocular pressure (IOP) delays the onset and decreases …

Glaucoma patients routinely take multiple medications, with multiple daily doses, for years or
even decades. Benzalkonium chloride (BAK) is the most common preservative in glaucoma …

Sustained-release dexamethasone coupled with intracameral antibiotics at the time of
phacoemulsification can provide antimicrobial and anti-inflammatory prophylaxis without the …